NDC 57926-040 - Finaplix-H
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57926-040
- Package NDCs from labels
- 57926-040-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2022-03-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Finaplix ® -H (trenbolone acetate) | Merck Sharp & Dohme Corp. | 2022-03-01 | OTC ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| trenbolone acetate | ACTIVE INGREDIENT | RUD5Y4SV0S | FINAPLIX-H (TRENBOLONE ACETATE) IMPLANT [MERCK SHARP & DOHME CORP.] | 1 | |
| trenbolone | ACTIVE MOIETY | P53R4420TR | FINAPLIX-H (TRENBOLONE ACETATE) IMPLANT [MERCK SHARP & DOHME CORP.] | 1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.